Ottawa, Feb. 19, 2025 (GLOBE NEWSWIRE) -- The global viral vector and plasmid DNA manufacturing market size was valued at USD 7.19 billion in 2024 and is expected to be worth around USD 46.02 billion ...
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "Viral Vector and Plasmid DNA: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for viral ...
(MENAFN- GlobeNewsWire - Nasdaq) According to Nova One Advisor, the global viral vector & plasmid DNA manufacturing size is calculated at USD 7.54 billion in 2025 and is expected to surpass around USD ...
DUBLIN--(BUSINESS WIRE)--The "Global Viral Vector and Plasmid Manufacturing Market: Focus on Vector Type, Application, Disease, 5 Region's Data, 15 Countries' Data, Patent Landscape and Competitive ...
The Viral Vector and Plasmid DNA Manufacturing Market refers to the industrial processes and services that enable the production of viral vectors and plasmid DNA used in gene therapies, vaccine ...
Plasmid DNA lies at the heart of viral and mRNA vector production because it provides the coding sequences for gene-based advanced therapy medicinal products (ATMPs). Its manufacture is therefore ...
Dublin, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The "Viral Vector and Plasmid DNA Manufacturing Market - Global Industry Size, Share, Trends Opportunity, and Forecast 2018-2028" report has been added to ...
Journal of Experimental Botany, Vol. 38, No. 194 (September 1987), pp. 1507-1516 (10 pages) Five Nicotiana species (N. benthemiana, N. debneyi, N. occidentalis, N ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback